BeOne Medicines Ltd (6160N) Stock Statistics & Valuation Metrics
Total Valuation
BeOne Medicines Ltd has a market cap or net worth of MXN 778.04B. The enterprise value is MXN 231.34B.
- Market Cap
- MXN 778.04B
- Enterprise Value
- MXN 231.34B
Share Statistics
BeOne Medicines Ltd has ― shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- ―
- Owned by Insiders
- ―
- Owned by Institutions
- 10.22%
Financial Efficiency
BeOne Medicines Ltd’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 4.76%.
- Return on Equity (ROE)
- 0.07
- Return on Assets (ROA)
- 0.03
- Return on Invested Capital (ROIC)
- 4.76%
- Return on Capital Employed (ROCE)
- 0.07
- Revenue Per Employee
- 445.91K
- Profits Per Employee
- 23.95K
- Employee Count
- 12,000
- Asset Turnover
- 0.65
- Inventory Turnover
- 1.30
Valuation Ratios
The current PE Ratio of BeOne Medicines Ltd is 62.04. BeOne Medicines Ltd’s PEG ratio is 0.03.
- PE Ratio
- 62.04
- PS Ratio
- 6.25
- PB Ratio
- 7.91
- Price to FCF
- 29.14
- Price to Operating Cash Flow
- 27.51
- PEG Ratio
- 0.03
Income Statement
In the last 12 months, BeOne Medicines Ltd had revenue of 5.35B and earned 287.36M in profits. Earnings per share was 0.20.
- Revenue
- 5.35B
- Gross Profit
- 4.56B
- Operating Income
- 447.80M
- Pretax Income
- 417.47M
- Net Income
- 287.36M
- EBITDA
- 589.69M
- Earnings Per Share (EPS)
- 0.20
Cash Flow
In the last 12 months, operating cash flow was 1.49B and capital expenditures -175.33M, giving a free cash flow of 1.31B billion.
- Operating Cash Flow
- 1.49B
- Free Cash Flow
- 1.31B
- Free Cash Flow per Share
- 0.91
Dividends & Yields
BeOne Medicines Ltd pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 3.44%
- Earnings Yield
- 1.60%
Important Dates
BeOne Medicines Ltd upcoming earnings date is Nov 06, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 05, 2026
- Next Earnings Date
- Nov 06, 2026
- Ex-Dividend Date
- ―
Financial Position
BeOne Medicines Ltd as a current ratio of 3.41, with Debt / Equity ratio of 25.06%
- Current Ratio
- 3.41
- Quick Ratio
- 3.08
- Debt to Market Cap
- 0.06
- Net Debt to EBITDA
- -5.93
- Interest Coverage Ratio
- 7.68
Taxes
In the past 12 months, BeOne Medicines Ltd has paid 130.11M in taxes.
- Income Tax
- 130.11M
- Effective Tax Rate
- 0.31
Enterprise Valuation
BeOne Medicines Ltd EV to EBITDA ratio is 30.97, with an EV/FCF ratio of 26.04.
- EV to Sales
- 5.58
- EV to EBITDA
- 30.97
- EV to Free Cash Flow
- 26.04
- EV to Operating Cash Flow
- 22.97
Balance Sheet
BeOne Medicines Ltd has MXN 5.10B in cash and marketable securities with MXN 1.14B in debt, giving a net cash position of MXN 3.95B billion.
- Cash & Marketable Securities
- MXN 5.10B
- Total Debt
- MXN 1.14B
- Net Cash
- MXN 3.95B
- Net Cash Per Share
- ―
- Tangible Book Value Per Share
- MXN 3.53
Margins
Gross margin is 87.82%, with operating margin of 15.06%, and net profit margin of 10.70%.
- Gross Margin
- 87.82%
- Operating Margin
- 15.06%
- Pretax Margin
- 14.16%
- Net Profit Margin
- 10.70%
- EBITDA Margin
- 18.03%
- EBIT Margin
- 15.50%
Analyst Forecast
The average price target for BeOne Medicines Ltd is MXN 661.42, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- MXN 661.42
- Price Target Upside
- ―
- Analyst Consensus
- Strong Buy
- Analyst Count
- 8
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―
Scores
- Smart Score
- 9
- AI Score
- ―
